Application no. and date | 10005567.2 (espacenet) (Federated) (European Patent Register), 20040308 | Patent/reg. no. and date | DK/EP 2216407, 20160113 | Publication date | 20100811 | Priority no. and date | US 452682 P, 20030307, US 454265 P, 20030312, US 454962 P, 20030313, US 455050 P, 20030313, US 462894 P, 20030414, US 463772 P, 20030417, US 465665 P, 20030425, US 465802 P, 20030425, US 469612 P, 20030509, US 493986 P, 20030808, US 494597 P, 20030811, US 506341 P, 20030926, US 510246 P, 20031009, US 510318 P, 20031010, US 518453 P, 20031107 | EP pub. no. and date |
EP 2216407 20100811 | Effective date | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street Henri A. Termeer Square
Cambridge, MA 02142, US | Applicant ref. no. | Alnylam ALN-021EPD1 | Inventor | Rajeev, Kallanthottathil, 25 Dean Road
Wayland, MA 01778-5023, US, Manoharan, Muthiah, 300 Third street
Cambridge, MA 01242, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Opponent | | IPC Class | C12N 15/113 (2010.01) | Title | Terapeutiske sammensætninger | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|